Sharekhan

Dabur India Ltd

Wed 30/04/2025,15:59:1 | NSE : DABUR

₹ 487.754.10 (0.85%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 483.60

Previous Close

₹ 483.65

Volume

2195362

Mkt Cap ( Rs. Cr)

₹86444.82

High

₹ 490.45

Low

₹ 482.35

52 Week High

₹ 672.00

52 Week Low

₹ 433.30

Book Value Per Share

₹ 58.47

Dividend Yield

1.12

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Dabur India Ltd

Your Vote -

Buy

63.49%

Hold

21.00%

Sell

15.52%

63.49%

7025 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

487.75

1111

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

1111

Option Chain

Analyzes market sentiment, predicts Dabur India Ltd' movement.

Call Price Open interest Strike Price Put Price Open interest

News

Media spotlight triggers stock stock attention, sentiment.

  • Dabur India - Update On Letter Dated April 15, 2025

    30 Apr 2025, 3:17PM Incorporation of step down wholly owned subsidiary of Dabur India Limited.
  • Dabur India - Disclosure under SEBI Takeover Regulations

    21 Apr 2025, 1:17PM Dabur India Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substanti
  • Dabur India - Copy of Newspaper Publication

    19 Apr 2025, 7:55PM Dabur India Limited has informed the Exchange about Copy of Newspaper Publication for loss of share certiifcates
  • Dabur India has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 8:20PM As of March 2025, 66.27% is owned by Promoters and 33.73% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 66.21% and Fore
  • Dabur India - Acquisition-XBRL

    15 Apr 2025, 5:36PM Dabur India Limited has informed the Exchange regarding Acquisition
  • Dabur India - Acquisition

    15 Apr 2025, 5:32PM Dabur India Limited has informed the Exchange about Acquisition
  • Dabur India - Incorporation

    15 Apr 2025, 5:13PM Dabur India Limited has informed the Exchange about Incorporation
  • Dabur India - Announcement under Regulation 30 (LODR)-Acquisition

    15 Apr 2025, 5:01PM Intimation of proposed incorporation of Step-down Wholly Owned Subsidiary Company of Dabur India Limited
  • Dabur India - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2025, 6:11PM Dabur India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31.
  • Dabur India - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Apr 2025, 6:10PM Dabur India Limited has informed the Exchange about Schedule of meet
  • Dabur India - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 6:04PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31.03.2025
  • Dabur India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    9 Apr 2025, 6:02PM Schedule of Investors' Conference Call for Dabur India Limited\r\nQ4 FY 2024-25 - Financial Results
  • Dabur India - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    7 Apr 2025, 1:59PM DABUR INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Dabur India - Change in Management

    7 Apr 2025, 1:43PM Dabur India Limited has informed the Exchange about change in Management
  • Dabur India - Announcement under Regulation 30 (LODR)-Change in Management

    7 Apr 2025, 1:37PM Change in Senior Management of the Company
  • Dabur India - Updates

    2 Apr 2025, 9:46PM Dabur India Limited has informed the Exchange regarding 'Quarterly Update - Q4 FY2024-25'.
  • Dabur India - Updates

    2 Apr 2025, 5:44PM Dabur India Limited has informed the Exchange regarding 'Update on Letter dated 01.04.2025'.
  • Dabur India - Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    2 Apr 2025, 5:36PM Update on Letter dated 01.04.2025
  • Dabur India - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    1 Apr 2025, 5:11PM Dabur India Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
  • Dabur India - Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    1 Apr 2025, 5:10PM Submission of Information under Regulation 30 of SEBI (LODR) Regulations, 2015
  • Dabur India - Action(s) taken or orders passed

    28 Mar 2025, 11:14PM Dabur India Limited has informed the Exchange about Action(s) taken or orders passed
  • Dabur India - Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Receipt Of Cautionary Letter

    28 Mar 2025, 11:04PM Submission of disclosure regarding cautionary letters received from Stock Exchanges.
  • Dabur India - Board Meeting Intimation

    28 Mar 2025, 5:48PM DABUR INDIA LIMITED has informed the Exchange about Board Meeting to be held on 07-May-2025 to consider and approve the Yearly Audited Financial resul
  • Dabur India - Trading Window-XBRL

    28 Mar 2025, 5:26PM DABUR INDIA LIMITED has informed the Exchange about Closure of Trading Window
  • Dabur India - Trading Window

    28 Mar 2025, 5:22PM Dabur India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Dabur India - Corporate Action-Board to consider Dividend

    28 Mar 2025, 5:13PM To consider recommendation of final dividend, if any, for the financial year ending on 31st March 2025.
  • Dabur India - Board Meeting Intimation for Considering Of Audited Financial Results For The Quarter/Financial Year Ending On

    28 Mar 2025, 5:07PM Dabur India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2025 ,inter alia, to consider and appr
  • Dabur India - Credit Rating

    21 Mar 2025, 2:50PM Dabur India Limited has informed the Exchange about Credit Rating
  • Dabur India - Announcement under Regulation 30 (LODR)-Credit Rating

    21 Mar 2025, 2:42PM Intimation of Credit Rating under Regulations 30, 51(2) and 55 of SEBI (LODR) Regulations, 2015
  • Dabur India - Alteration Of Capital and Fund Raising-XBRL

    14 Feb 2025, 5:40PM Dabur India Limited has informed the Exchange regarding Allotment of Securities
  • Dabur India - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    14 Feb 2025, 5:35PM Allotment of Equity Shares under Dabur Employees Stock Option Scheme 2000
  • Dabur India - ESOP/ESOS/ESPS

    14 Feb 2025, 5:33PM Dabur India Limited has informed the Exchange regarding of 3229 Options.
  • Dabur India - Action(s) taken or orders passed

    5 Feb 2025, 4:00PM Dabur India Limited has informed the Exchange about Action(s) taken or orders passed
  • Dabur India - Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    5 Feb 2025, 3:48PM Submission of Information under Regulation 30 of SEBI (LODR) Regulations, 2015
  • Dabur India - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Feb 2025, 7:00PM Dabur India Limited has informed the Exchange about Schedule of meet and Presentation
  • Dabur India - Action(s) taken or orders passed

    4 Feb 2025, 6:54PM Dabur India Limited has informed the Exchange about Action(s) taken or orders passed
  • Dabur India - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Feb 2025, 6:51PM Dabur India Limited has informed the Exchange about Transcript
  • Dabur India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Feb 2025, 6:43PM We wish to inform you that the officials of the Company\r\nshall be attending the Nuvama India Conference 2025 on Monday, February 10, 2025 at The St.
  • Dabur India - Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    4 Feb 2025, 6:36PM Submission of Information under Regulation 30 of SEBI (LODR) Regulations, 2015
  • Dabur India - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    4 Feb 2025, 6:30PM Transcript of Investors' Conference Call for Dabur India Limited - Q3 FY 2024-25 Financial Results
  • Dabur India

    16 Apr 2025 , 10:25AM Dabur International FZE, the step-down wholly owned subsidiary company of Dabur decided to incorporate new entity in UK, which will be step-down wholly owned subsidiary of Dabur International FZE for FMCG sales and distribution.
  • Dabur India Q4FY25 pre-quarter update

    3 Apr 2025 , 10:03AM Dabur India Q4FY25 pre-quarter update: Weak Q4
  • Stock update: Dabur India Q3FY25 (Consolidated) result update

    1 Feb 2025 , 10:56AM Stock update: Dabur India Q3FY25 (Consolidated) result update – Soft Q3; gradual recovery eyed
  • Dabur India

    13 Jan 2025 , 2:40PM The company has acquired 1,25,90,070 Cumulative Redeemable Preference Shares, comprising 51% of the total paid up Preference Share Capital of SESA Care for a total consideration of Rs. 12.6 crore. The estimated enterprise value of Sesa Care is between Rs. 315 crore and Rs. 325 crore, which includes debt of Rs. 299 crore, secured by Dabur's corporate guarantee. The deal is valued at 2.4-2.5x the revenues of the acquired entity. Sesa is a prominent brand in the ayurvedic hair oil space and will complement existing hair care portfolio and enhance Dabur's presence in the hair care market. Positive.
  • Dabur India: Q3FY2025 pre quarter update

    6 Jan 2025 , 11:35AM Dabur India: Q3FY2025 pre quarter update – low single-digit revenue growth; margins lower y-o-y
  • Stock update: Dabur India Q2FY2025 (Consolidated) result update

    31 Oct 2024 , 11:21AM Stock update: Dabur India Q2FY2025 (Consolidated) result update – One-offs impacted Q2 performance
  • Dabur signs MoU with govt of Tamil Nadu

    22 Aug 2024 , 12:14PM Dabur signs MoU with govt of Tamil Nadu to set-up new manufacturing facility'
  • Stock update: Dabur India Q1FY2025

    2 Aug 2024 , 12:24PM Stock update: Dabur India Q1FY2025 (Consolidated) result update – Good Q1
  • Stock update: Dabur India

    9 Jul 2024 , 10:44AM Stock update: Dabur India – Good Q1 update; volume growth trend to improve
  • Dabur India: Q1FY25 pre quarter update

    8 Jul 2024 , 11:32AM Dabur India: Q1FY25 pre quarter update -mid-single digit volume growth despite lower out-of-home sales
  • Stock update: Dabur India

    7 Jun 2024 , 12:50PM Stock update: Dabur India – Focus on improving volume growth ahead
  • Stock update: Dabur India Q4FY2024 (Consolidated) result update

    3 May 2024 , 11:05AM Stock update: Dabur India Q4FY2024 (Consolidated) result update – Good Q4; focus on improving volume growth ahead
  • Stock update: Dabur India Q4FY2024 (Consolidated) result update

    3 May 2024 , 11:00AM Stock update: Dabur India Q4FY2024 (Consolidated) result update – Good Q4; focus on improving volume growth ahead
  • Stock update: Dabur India Q3FY2024 (Consolidated) result update

    1 Feb 2024 , 11:09AM Stock update: Dabur India Q3FY2024 (Consolidated) result update – Decent Q3; long-term growth strategies in place
  • Dabur India: Q3FY2024 performance update

    5 Jan 2024 , 12:40PM Dabur India: Q3FY2024 performance update – witnessed sequential improvement in demand in Q3
  • Dabur India

    20 Nov 2023 , 11:05AM The company is planning to set up a new manufacturing unit or factory in South India in less than a year’s time to scale up its business in the region. Dabur recorded a significant increase in its domestic sales from South India, now accounting for 20% of its total sales, and has witnessed a doubling of its business in the region over the past 5-6 years. Long term positive for Dabur.
  • Dabur India

    20 Nov 2023 , 11:05AM The company is planning to set up a new manufacturing unit or factory in South India in less than a year’s time to scale up its business in the region. Dabur recorded a significant increase in its domestic sales from South India, now accounting for 20% of its total sales, and has witnessed a doubling of its business in the region over the past 5-6 years. Long term positive for Dabur.
  • Dabur India

    16 Nov 2023 , 9:55AM Dabur and Dermoviva have been dismissed as defendants in federal cases, which were consolidated as a Multi-District Litigation, also referred to as MDL, before the United States District Court for the Northern District of Illinois, for lack of personal jurisdiction as neither Dabur nor Dermoviva manufactured, marketed, distributed or sold hair relaxer products in the US. Hence, now only Namaste remains as a defendant in these cases along with many other industry players such as L'Oreal, SoftSheen/Carson, Luster Products Inc, Avion Industries, Inc.; PDC Brands (Parfums de Coeur, Ltd), Revlon etc. Lawsuit does not concern any Dabur brand or product and that Dabur India Limited is not a party to these suits. The sale of hair relaxer products by Namaste forms less than 1% of the total consolidated turnover of Dabur India. – Positive read through for the stock
  • Dabur India

    15 Nov 2023 , 10:10AM Dabur Group Chairman Mohit V. Burman and Director Gaurav V. Burman – has been listed in an FIR lodged by Mumbai Police in the Mahadev betting app case. However the group has come out with an official announcement of not receiving any communication on any such FIR. If this information is true, it appears to be a mischievous act driven by malicious intent and is devoid of any facts. Dabur promoter alleged vested . The group has allerged that vested interests are attempting to block its acquisition of a stake in Religare Enterprises – sentimentally negative for Dabur India.
  • Stock update: Dabur India Q2FY2024 (Consolidated) result update

    3 Nov 2023 , 11:49AM Stock update: Dabur India Q2FY2024 (Consolidated) result update – Soft Q2; festive, winter season to drive growth in H2
  • Dabur India Q2FY2024 (Consolidated)

    2 Nov 2023 , 3:35PM Dabur India Q2FY2024 (Consolidated) results – In-line performance
  • Dabur India

    19 Oct 2023 , 11:25AM The company’s subsidiaries in US and Canada are amongst the companies sued in the US and Canada by customers alleging that the use of hair relaxer products had caused ovarian cancer, uterin cancer and other health issues. About 5400 cases are filed against several companies and are in the pleadings and early discover. Since the cases are in the initial stage of litigation, any final quantum of claim amount is neither probable nor estimable – negative read through for Dabur India.
  • Dabur India: Q2FY24 pre-quarter update

    6 Oct 2023 , 2:17PM Dabur India: Q2FY24 pre-quarter update – Mid-high single-digit growth; margin expansion to be reinvested for company’s growth
  • Stock update: Dabur India

    18 Sep 2023 , 10:42AM Stock update: Dabur India – Focus on accelerating growth ahead
  • Dabur India

    3 Aug 2023 , 1:41PM According to media reports, Cancer-causing agent detected in Dabur Honey according to lab test reports. The amount of HMF identified in the sample of honey from Dabur was 176.7mg. This quantity should never exceed 80mg in accordance with the established standards. It was found to be present in the second Dabur Sample in an amount of 97.250mg – negative read through for the stock as Dabur Honey is one of the leading brand in the honey space. Such reports might have impact on the sales of the brand.
  • Dabur India: Q1FY2024 (consolidated) pre-quarter update

    7 Jul 2023 , 11:17AM Dabur India: Q1FY2024 (consolidated) pre-quarter update – high single digit revenue growth; OPM to remain flat due to higher ad-spends
  • Dabur India: Q4FY23 pre-quarter update

    6 Apr 2023 , 11:31AM Dabur India: Q4FY23 pre-quarter update – Revenue growth expected in mid single-digit; margins likely to remain lower y-o-y
  • Dabur India

    17 Jan 2023 , 11:19AM The company opened six new exclusive outlets of NewU increasing the network count to 100 outlets across 40 cities. NewU is a one-stop beauty destination that gives consumers access to a comprehensive range of cosmetics, skin care, hair care, personal grooming and fragrances. NewU outlets are operated by H & B Stores Ltd which is a 100% subsidiary of Dabur India Ltd. View: The opening of new stores is in-line with the company’s strategy to expand its retail footprint across India and double store count in the next 2 years.
  • Dabur India

    6 Jan 2023 , 3:18PM Dabur India: Q3FY23 business update
  • Dabur India

    6 Jan 2023 , 3:17PM Dabur India: Q3FY23 business update
  • Dabur completes acquisition of stake in Badshah Masala

    3 Jan 2023 , 12:11PM FMCG giant Dabur acquires a 51% majority stake in Badshah Masala
  • Dabur India

    3 Jan 2023 , 10:53AM The company has acquired 51% equity shareholding of Badshah from its shareholders upon fulfilment of terms and conditions as per SPA and SNA and the said transaction has been completed on 2nd January 2023. Badshah will be wholly owned subsidiary of the company. The acquisition will help Dabur’s food business to scale up to Rs500crore over the next three years. Further the company is planning to do a capex of Rs325crore in capacity expansion, which will add Rs900crore revenues by FY2027. The acquisition will be cash EPS accretive from FY2024 – Positive for Dabur India; it remains one of our preferred picks in the FMCG space.
  • Dabur India

    21 Dec 2022 , 9:46AM Gyan Enterprises Pvt Ltd. and Chowdry Associates - entities of Barman family, who are a part of the majority shareholders of Dabur India Ltd, have sold ~1% shares through a block deal which was completed on 20th December 2022. The purpose of doing this transaction is to raise funds for financing some ventures in private hands of the Burman family.
  • Dabur India

    20 Dec 2022 , 10:03AM Dabur India: According to media reports, Dabur India’s promoter is likely to sell Rs800crore (or $100bn) worth of shares via block deal. The shares are likely to be sold upto 4% discount to the current market price at ~Rs565 per share View: Any correction in the stock price should be considered as an opportunity to enter the quality FMCG play. We have a Buy rating on Dabur India.
  • Dabur India

    7 Dec 2022 , 10:25AM The company plans to enter India’s feminine care market, which is currently dominated by multinational companies in India. Sanitary napkin in India is around Rs5,400crore market with overall penetration of just 22%. Penetration level of hygiene products in the rural market is much higher compared to urban market. The company will be launching the product under the brand name -fern and on the e-commerce platform.
  • Stock update: Dabur India Q1FY2023 (Consolidated) result update

    5 Aug 2022 , 11:43AM Stock update: Dabur India Q1FY2023 (Consolidated) result update - Decent Q1; innovation, distribution expansion to drive growth
  • Dabur India Q1FY2023 (Consolidated) results

    4 Aug 2022 , 8:49PM Dabur India Q1FY2023 (Consolidated) results – performance in-line with expectation; mid-single digit volume growth; OPM at 19.3%
  • Dabur India

    14 Jul 2022 , 10:27AM The company has increased its takes to 100% from 76% earlier in its Bangladesh subsidiary – Asian Consumer Private for Bangladeshi Taka[BDT] 60crore (INR 51crore). Dabur is acquiring stake from Advance Chemical Industries for cash consideration. Asian Consumer Private, Bangladesh is in the business of manufacturing and marketing of the consumer care products in Bangladesh and has revenues of BDT158.8crore (INR 135crore); revenues grew at CAGR of 10% over FY2020-22. The deal is valued at 1.6x its FY2024E sales.
  • Dabur India: Q1FY2023 pre-quarter update

    6 Jul 2022 , 2:16PM Dabur India: Q1FY2023 pre-quarter update – Mid single digit revenue growth; margins to decline on y-o-y basis
  • Stock update: Dabur India Q4FY2022 (Consolidated) result update

    6 May 2022 , 11:11AM Stock update: Dabur India Q4FY2022 (Consolidated) result update - Soft quarter; market share gain continues
  • Dabur India

    23 Feb 2022 , 3:10PM According to media reports, the company has tied up with energy provider Indian Oil in an exclusive partnership, which will provide direct access of Dabur’s products to around 14 crore Indane LPG consumer households across India.
  • Stock update: Dabur India Q3FY2022 (Consolidated) result update

    4 Feb 2022 , 3:04PM Stock update: Dabur India Q3FY2022 (Consolidated) result update - Strong market share gains pave growth path
  • Stock update: Dabur India Q3FY2022 (Consolidated) result update

    4 Feb 2022 , 3:04PM Stock update: Dabur India Q3FY2022 (Consolidated) result update - Strong market share gains pave growth path
  • Dabur India Q3FY2022 (consolidated) result

    3 Feb 2022 , 10:24AM Dabur India Q3FY2022 (consolidated) result – price led growth across categories; volume growth of 2%
  • Dabur India

    21 Sep 2021 , 10:37AM The company forayed into the face wash category by extending the Vatika brand into the segment. The company expects Dabur Vatika Face Wash range, which has been exclusively launched on e-commerce platform Flipkart, would strengthen its presence in the personal care market. The company expects Dabur Vatika Face Wash range, which has been exclusively launched on e-commerce platform Flipkart, would strengthen its presence in the personal care market.
  • Dabur India

    15 Sep 2021 , 3:25PM According to media reports, Dabur India has taken price increase of 2-2.5% in its hair oil portfolio. The price of 275ml Dabur Amla hair oil pack has been increased by 2.9% to Rs138 & 450ml bottle by 5% to Rs209. Dabur Anmol 500ml pack was costlier by Rs14, Vatika Coconut hair oil 300ml was hiked by 2.3% to Rs179. This price hikes are undertaken in-line with increase in the key input prices such as LLP and Packaging cost. Input cost inflation was ~10% in Q1FY22 and the company took price hike of just 3% in Q1. The recent price hike in hair oil portfolio is in-line with the company’s strategy of calibrated price hikes in the product portfolio.
  • Dabur India

    11 Aug 2021 , 10:05AM According to media reports, Burman Family is set to give up control in Aviva Life by selling stake reducing its stake to 26% from 51% earlier. According to the current actuarial valuations, 25% stake sell with fetch value of Rs1500crore. Burman family has sharpened its focus on the FMCG business under Dabur India. This may see the family monetize stakes in certain businesses and mobilize the proceeds to expand the product range and boost Dabur’s FMCG businesses
  • Dabur India: Strong performance

    4 Aug 2021 , 11:39AM Dabur India: Strong performance; Medium term growth prospects intact
  • Dabur India Q1FY2022 (consolidated)

    3 Aug 2021 , 3:31PM Beat on all fronts; Domestic volume growth 34% ahead of our as well street expectation
  • Dabur India

    24 Jun 2021 , 10:17AM Dabur India: The company to set up largest unit in Madhya Pradesh with an investment of Rs550crore
  • Dabur breaks ground for new factory in Madhya Pradesh

    23 Jun 2021 , 3:20PM To invest Rs 550 Crore in setting up most modern, environment-friendly unit
  • Dabur breaks ground for new factory in Madhya Pradesh

    23 Jun 2021 , 2:46PM To invest Rs 550 Crore in setting up most modern, environment-friendly unit
  • Dabur India: Q4FY2021 result update

    10 May 2021 , 10:37AM Q4 miss on volumes; Strong portfolio to aid steady growth ahead
  • Dabur India Q4FY2021 (consolidated)

    7 May 2021 , 2:55PM Revenues grew by 25%+ on low base; OPM remained flat y-o-y at 18.9%
  • Dabur India: Stock update

    23 Apr 2021 , 9:15AM Dabur India: Stock update – health and oral care would lead growth ahead
  • Dabur India

    5 Mar 2021 , 10:42AM Dabur India expanded its Vatika portfolio with the launch of Dabur Vatika Select premium range of shampoos. Dabur Vatika Select is initially available on Flipkart and will soon be rolled out through regular retail channels.
  • Dabur India

    19 Feb 2021 , 10:24AM According to media reports, Promoters of Dabur India has sold 0.5% stake (around 88 lakh shares) at Rs510-520 per share (CMP – Rs520) for ~Rs460crore which we believe is mainly to increase its stake in Eveready Industries
  • Dabur India

    18 Jan 2021 , 11:20AM The company forays into the ghee category as part of its plans to expand product portfolio. The company, which has fast tracked launch of several new products after COVID-19, will launch 'Cow Ghee' exclusively on e-commerce platform Grofers. It is a natural immunity booster with antioxidant properties, improves digestion and is a good source of energy. Dabur had forayed into the edible oil segment with the launch of its cold pressed mustard oil.
  • Dabur India

    18 Jan 2021 , 11:16AM The company forays into the ghee category as part of its plans to expand product portfolio. The company, which has fast tracked launch of several new products after COVID-19, will launch 'Cow Ghee' exclusively on e-commerce platform Grofers. It is a natural immunity booster with antioxidant properties, improves digestion and is a good source of energy. Dabur had forayed into the edible oil segment with the launch of its cold pressed mustard oil.
  • Dabur India: Stock Update

    4 Nov 2020 , 10:32AM Dabur India: Stock Update- Healthy Q2; growth momentum to sustain
  • Dabur India Q2FY2021 first cut

    3 Nov 2020 , 3:05PM Dabur India Q2FY2021 first cut: Performance beats expectations; Volumes grew in double-digits
  • Dabur India: Viewpoint

    16 Oct 2020 , 10:52AM Dabur India: Viewpoint -Health care range & rural recovery to drive growth
  • Dabur India

    15 Sep 2020 , 9:59AM Dabur India: The Company forayed into the edible oil segment with the launch of its cold pressed mustard oil
  • Dabur India; Emami

    14 Sep 2020 , 12:10PM The centre has issued guidelines for patients recovering from the coronavirus disease which includes consuming Chyawanprash and performing yoga - This will further give boost to the sales of Chyawanprash in the domestic market; Dabur India being a leading player in the segment will be key beneficiary followed by Emami and other players
  • Dabur India

    4 Sep 2020 , 11:01AM In the AGM top management indicated that the Company will leverage the momentum in healthcare and immunity building products, particularly on its nine power brands such as chyawanprash and honey to build the business further through innovation, distribution enhancement and higher visibility. It has launched over 50 new products recently and within weeks of the pandemic outbreak introduced immunity-focused juices, immunity kits, hand sanitisers, antiseptic liquid and germ protection soaps. It launched series of new products exclusively for online markets such as apple cider vinegar and a baby care range
  • Dabur India

    27 Aug 2020 , 10:57AM Packaging solutions firm Tetra Pak and Dabur have partnered to launch the FMCG major’s new low calorie juice range in a different packaging format to remain competitive in the Rs 2500 crore packaged juice market which has players like ITC and PepsiCo. Further the demand for health & wellness products is increasing in the domestic market.
  • Dabur India

    10 Aug 2020 , 10:06AM Dabur India: The Company expands baby care product portfolio, launches 8 new Ayurveda-based products
  • Dabur India

    31 Jul 2020 , 10:18AM Dabur India: Viewpoint - Health & hygiene shines; rural recovery holds key to growth
  • Dabur India

    30 Jul 2020 , 3:39PM Dabur India (consolidated) Q1FY21 - mixed results; volume decline of ~10%; OPM expanded on y-o-y basis
  • Dabur India

    21 Jul 2020 , 10:41AM Dabur: The company files case against Marico, alleges rival copied packaging, bottle for Saffola Honey
  • Dabur India

    1 Jun 2020 , 12:31PM CRISIL reaffirmed its credit rating at AAA/Stable for long term bank facilities
  • Dabur India

    28 May 2020 , 10:11AM Dabur India: Viewpoint - Healthy portfolio to help in faster recovery
  • Dabur India

    27 May 2020 , 3:37PM Dabur India Q4FY2020 (consolidated) results - misses estimates; domestic sales volume declined by 12.6%
  • Dabur India

    14 May 2020 , 11:12AM The company has launched clinical trials to assess whether its flagship health product Chyawanprash can boost immunity against the covid-19
  • Dabur India

    15 Apr 2020 , 5:04PM Impact of extended lockdown on production and sales will be material - negative read through for the stock; FY2021 is expected to be affected by Covid-19 but recovery is anticipated by FY2022 (triggers like normal monsoon will support consumer demand)
  • Dabur India

    31 Jan 2020 , 11:05AM Dabur India – Decent performance in tough time
  • Dabur India

    30 Jan 2020 , 3:52PM Dabur India media interaction take away post Q3FY2020 results
  • Dabur India

    30 Jan 2020 , 3:10PM Dabur Q3FY2020 (consolidated) – better performance backed steady volume growth of ~5.6%
  • Dabur India

    9 Dec 2019 , 2:34PM The company has identified potential targets to acquire companies in the health care, foods and personal care space - positive for the stock as the move is in line with the company’s strategy of expanding its rural network to cover 55,000 villages by FY2020 and 60,000 by FY2021 from 44,000 currently.
  • Dabur India

    6 Nov 2019 , 10:59AM Dabur India: Viewpoint – Mixed performance; domestic volume growth stood at 5%
  • Dabur India

    5 Nov 2019 , 3:32PM Dabur India Q2FY2020 (consolidated) – revenue slightly misses estimates; higher margins and lower tax led to double digit PAT growth
  • Dabur India Q2 net profit rises by 7% YoY

    5 Nov 2019 , 2:27PM Q2 net profit at Rs. 403 crore for the quarter ended September 30, 2019
  • Dabur India: Q1FY20 result viewpoint

    22 Jul 2019 , 1:05PM Q1FY20 result viewpoint – Staying strong in tough times
  • Dabur India: Viewpoint Q1FY19 update

    2 Aug 2018 , 3:19PM Dabur India: Viewpoint Q1FY19 update – Robust volume growth in Q1; growth momentum to sustain
  • Dabur registers strong operating performance in Q1

    31 Jul 2018 , 2:20PM Dabur India Q1FY19 (consolidated) - Robust domestic volume growth of 21%; lower other income led to miss on bottom-line
  • Dabur India reports a strong all-round performance

    3 May 2018 , 12:14PM Despite 15% run-up in the stock price in last one month, we maintain our Positive view on the stock with 14-16% potential upside in view of up-gradation in earnings estimates and future growth prospects. Dabur remains one of our top picks in the FMCG space, as it will be one of the key beneficiaries of improving rural demand in the domestic market.
  • Growth momentum to sustain for Consumer goods and services

    11 Apr 2018 , 10:37AM In Q4FY2018, prices of some of the key inputs including palm oil, linear alkyl benzene, milk and sugar have remained benign on a y-o-y basis.
  • Dabur results in-line with expectations in Q3FY18

    31 Jan 2018 , 2:51PM Dabur Q3FY2018 consolidated results – in-line with expectation; revenues and PAT grew by in double digits
  • Dabur India is seeing early signs of rural revival

    1 Jan 2018 , 10:10AM Positive read through for the stock for Dabur India as the company is seeing early signs of rural revival and expect it to accelerate over the next four to five quarters.
  • Dabur India- healthy option with better growth prospects

    12 Dec 2017 , 10:19AM Positive viewpoint on the stock with 16-18% upside.
  • Dabur ropes in Amazon to boost foreign business

    27 Sep 2017 , 10:35AM Dabur ropes in Amazon to boost foreign business – positive for Dabur, will help to boost the revenue from foreign markets which is currently at 30%
  • Dabur India ties up with e-commerce major Amazon

    25 Sep 2017 , 11:55AM Dabur India: Has tied up with e-commerce major Amazon for an online ayurveda marketplace which will house all ayurvedic brands and products available in the country - Positive
  • Delhi HC orders Patanjali to stop Ads on Chyawanprash

    8 Sep 2017 , 9:36AM Delhi High Court ordered Baba Ramdev's Patanjali Ayurved to stop airing advertisements to promote its brand of Chyawanprash - positive for Emami.
  • Dabur India performs better than peers

    7 Aug 2017 , 1:01PM Dabur India: Q1FY2018 consolidated results – performance better than peers.

Key fundamentals

Evaluate the intrinsic value of Dabur India Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 7613.29 6844.09 6374.85 5562.8 4688.19
Liabilities 7613.29 6844.09 6374.85 5562.8 4688.19
Equity 177.2 177.18 176.79 176.74 176.71
Gross Profit 1839.08 1700.81 1733.82 1559.2 1380.77
Net Profit 1509.21 1373.26 1432.93 1381.89 1170.35
Cash From Operating Activities 1653.33 1561.91 1319.95 1704.17 1154.77
NPM(%) 16.52 15.81 17.51 19.23 18.54
Revenue 9135.6 8684.35 8179.5 7184.73 6309.8
Expenses 7296.52 6983.54 6445.68 5625.53 4929.03
ROE(%) 14.56 13.25 13.82 13.33 11.29

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
08 Nov 2024 2.75 275 1.13 572.55
19 Jul 2024 2.75 275 1.13 525.3
10 Nov 2023 2.75 275 1.13 517.9
21 Jul 2022 2.7 270 1.13 529.05
11 Nov 2021 2.5 250 1.13 617.05
29 Jul 2021 3 300 1.13 534.6
11 Nov 2020 1.75 175 1.13 513.8
13 Aug 2020 1.6 160 1.13 428.95
13 Nov 2019 1.4 140 1.13 447.25
07 Aug 2019 1.5 150 1.13 382.15
09 Nov 2018 1.25 125 1.13 425.3
04 Jul 2018 5 500 1.13 371.8
07 Nov 2017 1.25 125 1.13 315.25
05 Jul 2017 1 100 1.13 284.9
03 Nov 2016 1.25 125 1.13 282.2
29 Jun 2016 1 100 1.13 269.65
05 Nov 2015 1.25 125 1.13 271
29 Jun 2015 0.75 75 1.13 264.6
19 Sep 2014 1.25 125 1.13 226.9
27 Jun 2014 1 100 1.13 177.8
05 Nov 2013 0.75 75 1.13 169.25
21 Jun 2013 0.85 85 1.13 147.8
31 Oct 2012 0.65 65 1.13 135.3
27 Jun 2012 0.75 75 1.13 111.85
04 Nov 2011 0.55 55 1.13 100.15
29 Jun 2011 0.65 65 1.13 99.55
02 Nov 2010 0.5 50 1.13 102.95
03 Aug 2010 1.25 125 1.13 186.15
30 Oct 2009 0.75 75 1.13 147.25
29 Jun 2009 1 100 1.13 103.7
02 Feb 2009 0.75 75 1.13 90
19 Jun 2008 0.75 75 1.13 106.85
29 Oct 2007 0.75 75 1.13 107.35
16 Mar 2007 0.75 75 1.13 92.25
03 Nov 2006 1 100 1.13 139.9
21 Jun 2006 1 100 1.13 131.2
28 Oct 2005 1.5 150 1.13 162.75
29 Jun 2005 1.5 150 1.13 119.75
02 Nov 2004 1 100 1.13 72.2
15 Jun 2004 1.4 140 1.13 83.35
20 Nov 2003 0.6 60 1.13 59.75
14 Nov 2002 0 50 1.13 45.15
13 Aug 2002 0 0 1.13 51.75
19 Nov 2001 0 50 1.13 59.95
14 Aug 2001 0 50 1.13 59.9
23 May 2001 0 100 1.13 69.95
23 May 2001 0 100 1.13 62.1
0 50 1.13 738.75
0 30 1.13 808.95
0 20 1.13 351
0 35 1.13 310.6
0 30 1.13 243.2

Peers

Other companies within the same industry or sector that are comparable to Dabur India Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nureca Ltd 231.01 -1.70 0.00 487.45 -17.94 0.00
Procter and Gamble Hygiene and Healthcare Ltd 14243.00 -0.81 64.58 1582.26 2079.50 1.79
Godrej Industries Ltd 1083.90 -1.76 75.01 16412.44 178.08 0.00
Colgate-Palmolive (India) Ltd 2587.40 -2.15 48.15 13257.96 4866.65 2.24

Company Info

1884 - Established by Dr. S K Burman at Kolkata 1896 - First production unit established at Garhia 1919 - First R&D unit established Early 1900s - Production of Ayurvedic medicines Dabur identifies nature-based Ayurvedic medicines as its area of specialisation. It is the first Company to provide health care through scientifically tested and automated production of formulations based on our traditional science. 1930 - Automation and upgradation of Ayurvedic products manufacturing initiated 1936 - Dabur (Dr. S K Burman) Pvt. Ltd. Incorporated 1940 - Personal care through AyurvedaDabur introduces Indian consumers to personal care through Ayurveda, with the launch of Dabur Amla Hair Oil. So popular is the product that it becomes the largest selling hair oil brand in India. 1949 - Launched Dabur Chyawanprash in tin pack Widening the popularity and usage of traditional Ayurvedic products continues. The ancient restorative Chyawanprash is launched in packaged form, and becomes the first branded Chyawanprash in India. 1957 - Computerisation of operations initiated 1970 - Entered Oral Care & Digestives segment Addressing rural markets where homemade oral care is more popular than multinational brands, Dabur introduces Lal Dant Manjan. With this a conveniently packaged herbal toothpowder is made available at affordable costs to the masses. 1972 - Shifts base to Delhi from Calcutta 1975 - The Company was incorporated on 16th September for manufacture of high grade edible & industrial guargum powder and its sophisticated derivatives. It was incorporated in the name of Vishal Chemical (India) Ltd. 1978 - Launches Hajmola tablet Dabur continues to make innovative products based on traditional formulations that can provide holistic care in our daily life. An Ayurvedic medicine used as a digestive aid is branded and launched as the popular Hajmola tablet. 1979 - Dabur Research Foundation set up 1979 - Commercial production starts at Sahibabad, the most modern herbal medicines plant at that time 1981 - On 19th September, the name was changed to Vidogum and Chemicals Ltd. The capacity of the plant was 2700 tpa of modified and refined guargum powder and derivatives such as oxidised guargum, carboxymethylated guargum, sydoxalkylated, guargum and similar carbo hydrate modification. It was promoted by Dabur (S. K. Burman) Pvt. Ltd. and founded in 1884 in Calcutta. The company manufacture herbal and Ayurvedic medicines and cosmetics in India. The other products are Dabur Amla Hair Oil, Badur Chavanprash, Pudin Hara etc. - The company undertook to set up a unit at Matsya Industrial Estate, Alwar, Rajasthan for manufacture of edible and industrial grade guargum powder and its derivatives. 1984 - Dabur completes 100 years 1988 - Launches pharmaceutical medicines 1989 - Care with fun The Ayurvedic digestive formulation is converted into a children's fun product with the launch of Hajmola Candy. In an innovative move, a curative product is converted to a confectionary item for wider usage. 1992 - A new range of coconut oil under the brand name `Anmol' was launched. The company developed Dab 10, an intermediate for anti-cancer drug namely Taxol. - The Company undertook to implement a phytopharma project at Ghaziabad U.P. This unit would manufacture a specialised anti cancer drug Taxot apart from manufacture of chemical intermediary for cancer drug and Terfenadine a non sedative anti allergic drug. The installed capacity of Taxot, the intermediate drug and anti allergic drug would be `6 Kg, 40 Kgs. and 18 tonnes respectively. - The company entered into a joint venture agreement with M/s. Guldenhorst BV Netherland to form a company for manufacture and marketing of all types of bubble gum, chewing gum, toffees, chocolate and cocoa related products, sugar based spreading creams etc. The company co-promoted Dabur Finance Ltd. to carry on the business of leasing, financing etc. - 45,50,520 shares allotted. Pursuant to a scheme of amalgamation of Dabur with Vidogum. 1994 - New products launched were `Dentacare,' Vatika and Lactonic which were well received in the market. - An integrated facility was designed at Alwar for manufacture of Ayurvedic Veterinary range at Alwar, a joint venture in technical collaboration with Shikobo Ltd., Japan to extend the range of natural gum products into speciality products. - The company also undertook to set up a project in Himachal Pradesh for manufacture of Hajmola, honey, Gulabari, Pudin Hara, Lavan Bhaskar Churna and soft gel capsules, part of the existing range of products. - At its Sahibabad plant, the company undertook to install various balancing equipments, mechanise operations, hitherto performed manually, instal reverse Osmosis plant, a concentration plant for extraction of herbs, barks, roots, seed etc. - The company also undertook to upgrade amla pulping section, expand storage space for ayurvedic raw materials and to meet the cost of the installation of two additional DG sets. - The Company floated two companies a manufacturing unit in Egypt in the name of Dabur Egypt Ltd. and Dadur International Ltd. in BVI. The company entered into a joint venture with Seprache International Ltd. in the name of `Innova' Inc. For manufacture of anti cancer drug namely `Paclitaxel'. - The company signed a MOU with Osein Internatinal Ltd. for manufacture of biscuits, snack, foods & other products in India. 1995 - In addition to the existing products, the company exported products like an improved version of Chyawanprash (with more honey and less pungency) liquid form of Chyawanprash an aqueous based, hair vitalizer Melatonine etc. - 182,02,080 bonus equity shares issued in prop. 4:1. During November 1993, the company issued 57,00,000 equity shares of Rs 10 lakh at a prem. of Rs 85 per share of which the following were reserved for allotment on a preferential basis: (1) 2,64,000 sh ares to employees of the company's shareholders of group cos. (all were taken up); (2) 5,27,000 shares to NRIs (all were taken); (3) 11,40,000 shares to Indian Fin. Insts. (only 8,38,400) shares taken up; (4) 5,40,000 shares to FIIs (all were taken up); (5) 6,00,000 shares to Indian Mutual Funds (all were taken up). Balance 26,29,000 shares along with 3,01,600 shares not taken up by FIIs, issued to public. Additional 56,530 equity shares allotted. 1996 - The company launched Madhuvanni an anticough preparation. - A unit was being set up at Baddi for manufacture of Chywanprash Janma Ghunti, Lal Tail, Dashmularishta and Ashokarishta. Semi synthetic pacitaxel and Docetaxel and various front line anti cancer drugs were being produced both for domestic as well as export market. The company proposed to double the volume of the Katni plant and introduce modern technology in processing Amla with high productivity and improved quality. - The company undertook to set up a joint venture in Bangrain of France in the names of Dabon International Pvt. Ltd. Another joint venture viz. General de Confiteria Pvt. Ltd. commenced commerical production in April 1995. 1997 - The Company set up a new manufacturing unit with a high degree of automation at Baddi (H.P.), to produce company's well known brands viz. Chyawanprash, Janma Ghunti, Ayurvedic oils and Asva-Arishtas. A modern air conditioned packing line was commissioned at Sahibabad for homemade brands of ethnic pastes and line juices. - The Dabur India Ltd has formed a joint venture with Osem of Israel for the production of food product in India. The joint venture named as Excelcia Food Pvt Ltd will have the Rs.15 paid up capital in which Dabur will have 60 per cent stake while Osem will have the rest 40 per cent holding in the company. - The company extended its range of real fruit juice by offering mixed fruit juice and tomato juice. Its veterinary division launched `mastilep' for curing mastitis in cattle. - Dabur India launched a range of extruded snack foods, ready-to-use cooking pastes and sauces here on Thursday. - Dabur India is negotiating with Antonio Puig of Spain, the maker of the Paco Rabanne perfume range, and Kesling of France to set up joint ventures in the country as a part of its strategy to establish a strong presence in the personal care sector. - Dabur India Ltd, Great Eastern Shipping Company Ltd and Ranbaxy Laboratories Ltd. have signed agreements with NSDL to get their securities admitted for dematerialisation at NSDL. - Dabur Industries Ltd has signed a tripartite agreement with the National Securities Depository Ltd and MCS ltd for dematerialising Dabur shares, becoming the first MCG company to avail of the facility. - Dabur India Ltd is launching a new communication campaign this month to reposition its oldest brand - `Pudinhara'. 1998 - Dabur India Ltd on 19th January 1998 launched low sodium cooking salt called Nutrasalt in Chandigrah. - Dabur signed a joint venture with Bongrain International SA of France to form a new company called Dabon International Ltd - Dabur India Ltd has launched a range of ayurvedic health care products for dogs under the umbrella brand name Ayupet. - Dabur India Ltd (DIL) has commissioned consultancy firm Noble and Hewitt to script a employee stock option plan. - Dabur India has tied up with Godrej Foods for the manufacture and packaging of its `Real' range of fruit juices and fruit drinks in tetrapacks. 1999 - Dabur India Ltd has entered into an agreement with its Spanish partner Agrolimen to offload its 49 per cent stake in the joint venture company General De Confiteria India Ltd in favour of an Agrolimen group company. - Dabur Pharmaceuticals Limited (DPL) has set up its first overseas arm in Britain with a $5 million investment commitment and is considering similar ventures in Russia as well as South African countries. 2000 - The Company has taken Nestle SA to the Company Law Board (CLB) charging the latter with "arm-twisting" it as a majority shareholder in their biscuit manufacturing joint venture Excelcia Foods Ltd (EFL). - FMCG major Dabur, along with US insurance company Allstate and Prudential-ICICI joint venture have applied for life insurance license as the Insurance Regulatory and Development Authority . - The Company has divested its entire 40 per cent stake in the controversial joint venture Excelcia Foods with Swiss major Nestle SA for a token amount of Rs 10. - The Company sub-divide the fully paid-up equity shares of Rs. 10 each into 10 fully paid-up equity shares of Re. 1 each. - Three domestic pharma companies - Cadila Pharmaceuticals, Shantha Biotech and Dabur India have signed an agreement with the department of biotechnology (DBT) for developing and marketing basic molecules in leprosy, hepatitis and tumor disease segments. - Crisil reaffirmed the highest safety rating of `P1 ' to the company's Rs 100-crore commercial paper programme. Crisil has reaffirmed it's AA rating, indicating high safety, assigned to the Rs 20 crore non-convertible debenture issue of the company. - Dabur India Ltd., has launched Efarelle Comfort, a natural menstrual pain reliever. - Dabur India's ayurvedic specialities division has launched plain isabgol husk under the brand name Nature Care. 2001 - Dabur India Ltd. proposes to increase the number of directors on its board, by adding three new directors. 2002 - Dabur India Ltd has informed that Mr. Ninu Khanna would now be continuing as CEO & Director till the Date of the next Board Meeting scheduled to be held on January 22, 2002. 2002 - Dabur India Ltd has informed that Mr.Ninu Khanna has resigned as Chief Executive Officer and Director of the Company and the resignation has been accepted. - Dabur India Ltd has informed that the Compensation Committee has allotted 16660 fully paid equity shares of Re 1 each for cash at par to the employees of the Company. - Dabur India Ltd has informed that the Board of Directors has approved the restructuring of the Board. Mr A CBurman, Mr Sidharth Burman, Air Chief Marshal N C Suri (Retd), Mr S M Datta, Mr Raja Vijay Karan.Mr Ashok Goenka have resigned from the Directorship of the Company and the Board has accepted the same w e f April 1, 2002.Further, Mr V C Burman and Mr Pradip Burman have also resigned from the Whole-time Directorship of the Company. Mr V C Burman and Mr Pradip Burman will, however continue as Non-executive Directors of the Company. -Pradip Burman appointed as Whole time Director of Dabur India. -The Board of Directors of Dabur India Ltd has appointed Mr Sunil Duggal as Chief Executive Officer of the company wef July 01, 2002. 2003 -The fourth Largest FMCG, Dabur India Ltd has tied with Free Markets Inc. for using leading edge technologies to execute online markets for its procurement needs. -CRISIL assigned "CRISIL GVC LEVEL 2" rating for governance and value creation practices of the company. -Dabur has sued Pharmaseutical major Ranbaxy for telecasting the comparative commercial of "Pepfiz". -Dabur India has inducted Mr.Siddharth Burman as the chairman and Mr Sunil Duggal, Mr.P D Narang and Mr Charanjit Mohan as the directors of the 4-member board of Dabur India's global arm based in Dubai. -The company acquired 10,00,000 ordinary fully paid shares of 1 Pound Sterling each of Redrock Limited with this acquisition Redrock Limited has become a wholly owned subsidiary of the company. Redrock Limited is engaged in the business of manufacture and sale of various cosmetics, toiletries and health care products and operates from the Jebel Ali Free Trade Zone in Dubai. -Acquires equity in Shri Dhanwantry Educational Society -Dabur forges alliance with Dhanwantry -Dabur launch new Herbal pill for diabetics 2004 -Dabur set to acquire Egyptian hair oil brand Touch -Dabur India gets Tetra Pak award -Dabur India inks pact with Accenture for outsourcing -Implements `Spend visibility solution' software provided by FreeMarkets Inc to control costs and strengthen the company's procurement process -Dabur ties up Uttarnachal for cancer drug -Dabur India has acquired a Nigerian company African Consumer Care Ltd, a step precursor to its plans to go on-shore for manufacturing in the country -Dabur join hands with DLF for healthcare hub 2005 -Delists equity shares from The Calcutta Stock Exchange Association Ltd (CSE) with effect from January 27, 2005, - Completes the acquisition process of Balsara Hygiene Products Ltd & Besta Cosmetics Ltd on April 16, 2005. -Dabur signs Sonu Nigam to endorse cough drops -Dabur acquires Balsara's businesses for Rs.1.43 bn 2006 -Dabur's Director P D Narang appoints as Chairman of PTL -Dabur India secures prestigious National Award from ICSI -Dabur promoters acquires stake in Vishal Mega Mart -Dabur crosses $2 bln market cap, adopts US GAAP. - Approves FCCB/GDR/ADR up to $200 million -Dabur India has given the Bonus in the Ratio of 1:1 2007 -The Company has issued Bonus Shares in the Ratio of 1:2. -Dabur India decides to merge its wholly-owned subsidiary Dabur Foods Limited with itself to extract synergies and unlock operational efficiencies. The integration will also help Dabur sharpen focus on the high growth business of foods and beverages, and enter newer product categories in this space -Dabur India announced its foray into the organised retail business through a wholly-owned subsidiary, H&B Stores Ltd. Dabur will invest Rs 140 crores by 2010 to establish its presence in the retail market in India with a chain of stores on the Health & Beauty format. 2008 - Acquires Fem Care Pharma Dabur India acquires Fem Care Pharma, a leading player in the women's skin care market. Besides an entry into the high-growth skin care market with an established brand name FEM, this transaction also offers Dabur a strong platform to enter newer product categories and markets. -Dabur India - Launch of First Retail Store by Subsidiary Company 2009 - Dabur India Ltd has appointed Dr. Ajay Dua as an Additional Director of the Company under the category of Independent, Non Executive Director w.e.f. September 03, 2009. - Dabur launched Odomos Naturals, a range of personal application mosquito repellents packed with Aloe Vera and Citronella with two options, cream and lotion. -Dabur Red Toothpaste becomes the Dabur's ninth Billion Rupee brand. Dabur Red Toothpaste crosses the billion rupee turnover mark within five years of its launch. 2010 - Dabur India announced on Monday that it has acquired a leading personal care products company Hobi Kozmetik Group. - Dabur Acquires Namaste Group For $100 Million". - Dabur Chyawanprash was launched in Orange and Mango flavoured variants. - Dabur Amla Hair Oils enters Limca Book of Records for achieving a record feat of hosting the longest ever non-stop head massage marathon. - Dabur India has given the Bonus in the Ratio of 1:1 2011 - Dabur enters professional skin care market with the launch of OxyLife Professional Facial Kit, created exclusively for professional use. - Dabur India Ltd. launches its first-ever online shopping portal www.daburuveda.com. - Dabur India acquires 30-Plus from Ajanta Pharma. - Dabur India Ltd sets up new subsidiary in Sri Lanka Dabur Lanka (Pvt.) Ltd. - Dabur India Ltd launches Dabur Almond Hair Oil. 2012 - Namaste Cosmeticos Ltd, has been added as the Company's new step down subsidiary Company in Brazil. - Dabur India has expanded its range of fruit juices viz. R‚al Activ. - Mr. Lalit Malik has joined as Chief Financial Officer of the Company. 2013 -Dabur Is First Company To Be Listed On MCX-SX -Dabur Enters Yoghurt Drink Market With Brand Real Activ -Dabur Expands Skin Care Portfolio, launches Oxy Life Gel Bleach -Dabur Launches New Fruit Juice Range : Real SupaFruits -Dabur Enters Male Grooming Market -Dabur Launches Indias First Oral Health Portal -Dabur Vatika launches Hibiscus range of Shampoo, Hair Oil; Marks next big Innovation in Hair Care -Dabur Babool builds Oral Hygiene awareness among 80,000 school kids 2014 -Dabur India Ltd Announces 125% Interim Dividend -Dabur Launches Anmol Coconut Hair Oil with Jasmine -Dabur Chyawanprash announces "Immune India School Challenge 2014" -Dabur Launches India First Ayurvedic Medical Journal -Dabur enters Packaged Coconut Water market with Real Activ 2015 -Dabur India Ltd has inked an agreement with Starcom MediaVest Group (SMG). -Dabur India Ltd has introduced an array of professional salon facial products for men and women under the Oxlife brand -Dabur India has introduced the sugar-free version of its popular ayurvedic product Chyawanprash named Ratnaprash SugarFree 2016 -Dabur Unveils New Premium Natural Baby Care Brand -Dabur acquires South African cosmetic firm Discaria Trading -Dabur India launches fruit juice-based aerated drinks 2017 - Dabur India has tied up with e-commerce major Amazon for an online ayurveda marketplace which will house all ayurvedic brands and products available in the country. -Dabur India Ltd inaugurated a skill development centre for women here, as part of the company CSR campaign. - Dabur India launched an on-the-wheels lab to test honey so as to help reduce adulteration and ensure greater purity of the product. 2018 -Dabur completes acquisition of 2 personal care products firm in South Africa. 2019 -Dabur wins ICSI National Award for Excellence in Corporate Governance-2019. 2020 -Dabur Launches Ayurvedic Medicinal Hair Oil- Dabur Keratex in Kerala. -Dabur has launched the new baby care products on e-commerce platform Amazon. 2021 -Dabur enters the Health Food Drink category with 'Dabur Vita'. -Dabur launches New Vatika Enriched Coconut Hair Oil. 2022 -Dabur launches Virgin "Coconut Oil' -Dabur launches "Dabur Vedic Green Tea Detox Kahwa" -Dabur expands Real portfolio with the launch of Real Health Peanut Butter range. -Dabur acquires majority stake in Badshah Masala, ground spices & blended spices company. -Dabur Enters `Premium Black Tea Market' with Dabur Vedic Tea. 2023 -Dabur India concludes acquisition of 51% stake in Badshah Masala. 2024 -Dabur India Limited has informed the Exchange about Acquisition of Sesa Care Private Limited thorugh merger along with its foreign wholly owned subsidiary.

1884 - Established by Dr. S K Burman at Kolkata 1896 - First production unit established at Garhia 1919 - First R&D unit established Early 1900s - Production of Ayurvedic medicines Dabur identifies nature-based Ayurvedic medicines as its area of specialisation. It is the first Company to provide health care through scientifically tested and automated production of formulations based on our traditional science. 1930 - Automation and upgradation of Ayurvedic products manufacturing initiated 1936 - Dabur (Dr. S K Burman) Pvt. Ltd. Incorporated 1940 - Personal care through AyurvedaDabur introduces Indian consumers to personal care through Ayurveda, with the launch of Dabur Amla Hair Oil. So popular is the product that it becomes the largest selling hair oil brand in India. 1949 - Launched Dabur Chyawanprash in tin pack Widening the popularity and usage of traditional Ayurvedic products continues. The ancient restorative Chyawanprash is launched in packaged form, and becomes the first branded Chyawanprash in India. 1957 - Computerisation of operations initiated 1970 - Entered Oral Care & Digestives segment Addressing rural markets where homemade oral care is more popular than multinational brands, Dabur introduces Lal Dant Manjan. With this a conveniently packaged herbal toothpowder is made available at affordable costs to the masses. 1972 - Shifts base to Delhi from Calcutta 1975 - The Company was incorporated on 16th September for manufacture of high grade edible & industrial guargum powder and its sophisticated derivatives. It was incorporated in the name of Vishal Chemical (India) Ltd. 1978 - Launches Hajmola tablet Dabur continues to make innovative products based on traditional formulations that can provide holistic care in our daily life. An Ayurvedic medicine used as a digestive aid is branded and launched as the popular Hajmola tablet. 1979 - Dabur Research Foundation set up 1979 - Commercial production starts at Sahibabad, the most modern herbal medicines plant at that time 1981 - On 19th September, the name was changed to Vidogum and Chemicals Ltd. The capacity of the plant was 2700 tpa of modified and refined guargum powder and derivatives such as oxidised guargum, carboxymethylated guargum, sydoxalkylated, guargum and similar carbo hydrate modification. It was promoted by Dabur (S. K. Burman) Pvt. Ltd. and founded in 1884 in Calcutta. The company manufacture herbal and Ayurvedic medicines and cosmetics in India. The other products are Dabur Amla Hair Oil, Badur Chavanprash, Pudin Hara etc. - The company undertook to set up a unit at Matsya Industrial Estate, Alwar, Rajasthan for manufacture of edible and industrial grade guargum powder and its derivatives. 1984 - Dabur completes 100 years 1988 - Launches pharmaceutical medicines 1989 - Care with fun The Ayurvedic digestive formulation is converted into a children's fun product with the launch of Hajmola Candy. In an innovative move, a curative product is converted to a confectionary item for wider usage. 1992 - A new range of coconut oil under the brand name `Anmol' was launched. The company developed Dab 10, an intermediate for anti-cancer drug namely Taxol. - The Company undertook to implement a phytopharma project at Ghaziabad U.P. This unit would manufacture a specialised anti cancer drug Taxot apart from manufacture of chemical intermediary for cancer drug and Terfenadine a non sedative anti allergic drug. The installed capacity of Taxot, the intermediate drug and anti allergic drug would be `6 Kg, 40 Kgs. and 18 tonnes respectively. - The company entered into a joint venture agreement with M/s. Guldenhorst BV Netherland to form a company for manufacture and marketing of all types of bubble gum, chewing gum, toffees, chocolate and cocoa related products, sugar based spreading creams etc. The company co-promoted Dabur Finance Ltd. to carry on the business of leasing, financing etc. - 45,50,520 shares allotted. Pursuant to a scheme of amalgamation of Dabur with Vidogum. 1994 - New products launched were `Dentacare,' Vatika and Lactonic which were well received in the market. - An integrated facility was designed at Alwar for manufacture of Ayurvedic Veterinary range at Alwar, a joint venture in technical collaboration with Shikobo Ltd., Japan to extend the range of natural gum products into speciality products. - The company also undertook to set up a project in Himachal Pradesh for manufacture of Hajmola, honey, Gulabari, Pudin Hara, Lavan Bhaskar Churna and soft gel capsules, part of the existing range of products. - At its Sahibabad plant, the company undertook to install various balancing equipments, mechanise operations, hitherto performed manually, instal reverse Osmosis plant, a concentration plant for extraction of herbs, barks, roots, seed etc. - The company also undertook to upgrade amla pulping section, expand storage space for ayurvedic raw materials and to meet the cost of the installation of two additional DG sets. - The Company floated two companies a manufacturing unit in Egypt in the name of Dabur Egypt Ltd. and Dadur International Ltd. in BVI. The company entered into a joint venture with Seprache International Ltd. in the name of `Innova' Inc. For manufacture of anti cancer drug namely `Paclitaxel'. - The company signed a MOU with Osein Internatinal Ltd. for manufacture of biscuits, snack, foods & other products in India. 1995 - In addition to the existing products, the company exported products like an improved version of Chyawanprash (with more honey and less pungency) liquid form of Chyawanprash an aqueous based, hair vitalizer Melatonine etc. - 182,02,080 bonus equity shares issued in prop. 4:1. During November 1993, the company issued 57,00,000 equity shares of Rs 10 lakh at a prem. of Rs 85 per share of which the following were reserved for allotment on a preferential basis: (1) 2,64,000 sh ares to employees of the company's shareholders of group cos. (all were taken up); (2) 5,27,000 shares to NRIs (all were taken); (3) 11,40,000 shares to Indian Fin. Insts. (only 8,38,400) shares taken up; (4) 5,40,000 shares to FIIs (all were taken up); (5) 6,00,000 shares to Indian Mutual Funds (all were taken up). Balance 26,29,000 shares along with 3,01,600 shares not taken up by FIIs, issued to public. Additional 56,530 equity shares allotted. 1996 - The company launched Madhuvanni an anticough preparation. - A unit was being set up at Baddi for manufacture of Chywanprash Janma Ghunti, Lal Tail, Dashmularishta and Ashokarishta. Semi synthetic pacitaxel and Docetaxel and various front line anti cancer drugs were being produced both for domestic as well as export market. The company proposed to double the volume of the Katni plant and introduce modern technology in processing Amla with high productivity and improved quality. - The company undertook to set up a joint venture in Bangrain of France in the names of Dabon International Pvt. Ltd. Another joint venture viz. General de Confiteria Pvt. Ltd. commenced commerical production in April 1995. 1997 - The Company set up a new manufacturing unit with a high degree of automation at Baddi (H.P.), to produce company's well known brands viz. Chyawanprash, Janma Ghunti, Ayurvedic oils and Asva-Arishtas. A modern air conditioned packing line was commissioned at Sahibabad for homemade brands of ethnic pastes and line juices. - The Dabur India Ltd has formed a joint venture with Osem of Israel for the production of food product in India. The joint venture named as Excelcia Food Pvt Ltd will have the Rs.15 paid up capital in which Dabur will have 60 per cent stake while Osem will have the rest 40 per cent holding in the company. - The company extended its range of real fruit juice by offering mixed fruit juice and tomato juice. Its veterinary division launched `mastilep' for curing mastitis in cattle. - Dabur India launched a range of extruded snack foods, ready-to-use cooking pastes and sauces here on Thursday. - Dabur India is negotiating with Antonio Puig of Spain, the maker of the Paco Rabanne perfume range, and Kesling of France to set up joint ventures in the country as a part of its strategy to establish a strong presence in the personal care sector. - Dabur India Ltd, Great Eastern Shipping Company Ltd and Ranbaxy Laboratories Ltd. have signed agreements with NSDL to get their securities admitted for dematerialisation at NSDL. - Dabur Industries Ltd has signed a tripartite agreement with the National Securities Depository Ltd and MCS ltd for dematerialising Dabur shares, becoming the first MCG company to avail of the facility. - Dabur India Ltd is launching a new communication campaign this month to reposition its oldest brand - `Pudinhara'. 1998 - Dabur India Ltd on 19th January 1998 launched low sodium cooking salt called Nutrasalt in Chandigrah. - Dabur signed a joint venture with Bongrain International SA of France to form a new company called Dabon International Ltd - Dabur India Ltd has launched a range of ayurvedic health care products for dogs under the umbrella brand name Ayupet. - Dabur India Ltd (DIL) has commissioned consultancy firm Noble and Hewitt to script a employee stock option plan. - Dabur India has tied up with Godrej Foods for the manufacture and packaging of its `Real' range of fruit juices and fruit drinks in tetrapacks. 1999 - Dabur India Ltd has entered into an agreement with its Spanish partner Agrolimen to offload its 49 per cent stake in the joint venture company General De Confiteria India Ltd in favour of an Agrolimen group company. - Dabur Pharmaceuticals Limited (DPL) has set up its first overseas arm in Britain with a $5 million investment commitment and is considering similar ventures in Russia as well as South African countries. 2000 - The Company has taken Nestle SA to the Company Law Board (CLB) charging the latter with "arm-twisting" it as a majority shareholder in their biscuit manufacturing joint venture Excelcia Foods Ltd (EFL). - FMCG major Dabur, along with US insurance company Allstate and Prudential-ICICI joint venture have applied for life insurance license as the Insurance Regulatory and Development Authority . - The Company has divested its entire 40 per cent stake in the controversial joint venture Excelcia Foods with Swiss major Nestle SA for a token amount of Rs 10. - The Company sub-divide the fully paid-up equity shares of Rs. 10 each into 10 fully paid-up equity shares of Re. 1 each. - Three domestic pharma companies - Cadila Pharmaceuticals, Shantha Biotech and Dabur India have signed an agreement with the department of biotechnology (DBT) for developing and marketing basic molecules in leprosy, hepatitis and tumor disease segments. - Crisil reaffirmed the highest safety rating of `P1 ' to the company's Rs 100-crore commercial paper programme. Crisil has reaffirmed it's AA rating, indicating high safety, assigned to the Rs 20 crore non-convertible debenture issue of the company. - Dabur India Ltd., has launched Efarelle Comfort, a natural menstrual pain reliever. - Dabur India's ayurvedic specialities division has launched plain isabgol husk under the brand name Nature Care. 2001 - Dabur India Ltd. proposes to increase the number of directors on its board, by adding three new directors. 2002 - Dabur India Ltd has informed that Mr. Ninu Khanna would now be continuing as CEO & Director till the Date of the next Board Meeting scheduled to be held on January 22, 2002. 2002 - Dabur India Ltd has informed that Mr.Ninu Khanna has resigned as Chief Executive Officer and Director of the Company and the resignation has been accepted. - Dabur India Ltd has informed that the Compensation Committee has allotted 16660 fully paid equity shares of Re 1 each for cash at par to the employees of the Company. - Dabur India Ltd has informed that the Board of Directors has approved the restructuring of the Board. Mr A CBurman, Mr Sidharth Burman, Air Chief Marshal N C Suri (Retd), Mr S M Datta, Mr Raja Vijay Karan.Mr Ashok Goenka have resigned from the Directorship of the Company and the Board has accepted the same w e f April 1, 2002.Further, Mr V C Burman and Mr Pradip Burman have also resigned from the Whole-time Directorship of the Company. Mr V C Burman and Mr Pradip Burman will, however continue as Non-executive Directors of the Company. -Pradip Burman appointed as Whole time Director of Dabur India. -The Board of Directors of Dabur India Ltd has appointed Mr Sunil Duggal as Chief Executive Officer of the company wef July 01, 2002. 2003 -The fourth Largest FMCG, Dabur India Ltd has tied with Free Markets Inc. for using leading edge technologies to execute online markets for its procurement needs. -CRISIL assigned "CRISIL GVC LEVEL 2" rating for governance and value creation practices of the company. -Dabur has sued Pharmaseutical major Ranbaxy for telecasting the comparative commercial of "Pepfiz". -Dabur India has inducted Mr.Siddharth Burman as the chairman and Mr Sunil Duggal, Mr.P D Narang and Mr Charanjit Mohan as the directors of the 4-member board of Dabur India's global arm based in Dubai. -The company acquired 10,00,000 ordinary fully paid shares of 1 Pound Sterling each of Redrock Limited with this acquisition Redrock Limited has become a wholly owned subsidiary of the company. Redrock Limited is engaged in the business of manufacture and sale of various cosmetics, toiletries and health care products and operates from the Jebel Ali Free Trade Zone in Dubai. -Acquires equity in Shri Dhanwantry Educational Society -Dabur forges alliance with Dhanwantry -Dabur launch new Herbal pill for diabetics 2004 -Dabur set to acquire Egyptian hair oil brand Touch -Dabur India gets Tetra Pak award -Dabur India inks pact with Accenture for outsourcing -Implements `Spend visibility solution' software provided by FreeMarkets Inc to control costs and strengthen the company's procurement process -Dabur ties up Uttarnachal for cancer drug -Dabur India has acquired a Nigerian company African Consumer Care Ltd, a step precursor to its plans to go on-shore for manufacturing in the country -Dabur join hands with DLF for healthcare hub 2005 -Delists equity shares from The Calcutta Stock Exchange Association Ltd (CSE) with effect from January 27, 2005, - Completes the acquisition process of Balsara Hygiene Products Ltd & Besta Cosmetics Ltd on April 16, 2005. -Dabur signs Sonu Nigam to endorse cough drops -Dabur acquires Balsara's businesses for Rs.1.43 bn 2006 -Dabur's Director P D Narang appoints as Chairman of PTL -Dabur India secures prestigious National Award from ICSI -Dabur promoters acquires stake in Vishal Mega Mart -Dabur crosses $2 bln market cap, adopts US GAAP. - Approves FCCB/GDR/ADR up to $200 million -Dabur India has given the Bonus in the Ratio of 1:1 2007 -The Company has issued Bonus Shares in the Ratio of 1:2. -Dabur India decides to merge its wholly-owned subsidiary Dabur Foods Limited with itself to extract synergies and unlock operational efficiencies. The integration will also help Dabur sharpen focus on the high growth business of foods and beverages, and enter newer product categories in this space -Dabur India announced its foray into the organised retail business through a wholly-owned subsidiary, H&B Stores Ltd. Dabur will invest Rs 140 crores by 2010 to establish its presence in the retail market in India with a chain of stores on the Health & Beauty format. 2008 - Acquires Fem Care Pharma Dabur India acquires Fem Care Pharma, a leading player in the women's skin care market. Besides an entry into the high-growth skin care market with an established brand name FEM, this transaction also offers Dabur a strong platform to enter newer product categories and markets. -Dabur India - Launch of First Retail Store by Subsidiary Company 2009 - Dabur India Ltd has appointed Dr. Ajay Dua as an Additional Director of the Company under the category of Independent, Non Executive Director w.e.f. September 03, 2009. - Dabur launched Odomos Naturals, a range of personal application mosquito repellents packed with Aloe Vera and Citronella with two options, cream and lotion. -Dabur Red Toothpaste becomes the Dabur's ninth Billion Rupee brand. Dabur Red Toothpaste crosses the billion rupee turnover mark within five years of its launch. 2010 - Dabur India announced on Monday that it has acquired a leading personal care products company Hobi Kozmetik Group. - Dabur Acquires Namaste Group For $100 Million". - Dabur Chyawanprash was launched in Orange and Mango flavoured variants. - Dabur Amla Hair Oils enters Limca Book of Records for achieving a record feat of hosting the longest ever non-stop head massage marathon. - Dabur India has given the Bonus in the Ratio of 1:1 2011 - Dabur enters professional skin care market with the launch of OxyLife Professional Facial Kit, created exclusively for professional use. - Dabur India Ltd. launches its first-ever online shopping portal www.daburuveda.com. - Dabur India acquires 30-Plus from Ajanta Pharma. - Dabur India Ltd sets up new subsidiary in Sri Lanka Dabur Lanka (Pvt.) Ltd. - Dabur India Ltd launches Dabur Almond Hair Oil. 2012 - Namaste Cosmeticos Ltd, has been added as the Company's new step down subsidiary Company in Brazil. - Dabur India has expanded its range of fruit juices viz. R‚al Activ. - Mr. Lalit Malik has joined as Chief Financial Officer of the Company. 2013 -Dabur Is First Company To Be Listed On MCX-SX -Dabur Enters Yoghurt Drink Market With Brand Real Activ -Dabur Expands Skin Care Portfolio, launches Oxy Life Gel Bleach -Dabur Launches New Fruit Juice Range : Real SupaFruits -Dabur Enters Male Grooming Market -Dabur Launches Indias First Oral Health Portal -Dabur Vatika launches Hibiscus range of Shampoo, Hair Oil; Marks next big Innovation in Hair Care -Dabur Babool builds Oral Hygiene awareness among 80,000 school kids 2014 -Dabur India Ltd Announces 125% Interim Dividend -Dabur Launches Anmol Coconut Hair Oil with Jasmine -Dabur Chyawanprash announces "Immune India School Challenge 2014" -Dabur Launches India First Ayurvedic Medical Journal -Dabur enters Packaged Coconut Water market with Real Activ 2015 -Dabur India Ltd has inked an agreement with Starcom MediaVest Group (SMG). -Dabur India Ltd has introduced an array of professional salon facial products for men and women under the Oxlife brand -Dabur India has introduced the sugar-free version of its popular ayurvedic product Chyawanprash named Ratnaprash SugarFree 2016 -Dabur Unveils New Premium Natural Baby Care Brand -Dabur acquires South African cosmetic firm Discaria Trading -Dabur India launches fruit juice-based aerated drinks 2017 - Dabur India has tied up with e-commerce major Amazon for an online ayurveda marketplace which will house all ayurvedic brands and products available in the country. -Dabur India Ltd inaugurated a skill development centre for women here, as part of the company CSR campaign. - Dabur India launched an on-the-wheels lab to test honey so as to help reduce adulteration and ensure greater purity of the product. 2018 -Dabur completes acquisition of 2 personal care products firm in South Africa. 2019 -Dabur wins ICSI National Award for Excellence in Corporate Governance-2019. 2020 -Dabur Launches Ayurvedic Medicinal Hair Oil- Dabur Keratex in Kerala. -Dabur has launched the new baby care products on e-commerce platform Amazon. 2021 -Dabur enters the Health Food Drink category with 'Dabur Vita'. -Dabur launches New Vatika Enriched Coconut Hair Oil. 2022 -Dabur launches Virgin "Coconut Oil' -Dabur launches "Dabur Vedic Green Tea Detox Kahwa" -Dabur expands Real portfolio with the launch of Real Health Peanut Butter range. -Dabur acquires majority stake in Badshah Masala, ground spices & blended spices company. -Dabur Enters `Premium Black Tea Market' with Dabur Vedic Tea. 2023 -Dabur India concludes acquisition of 51% stake in Badshah Masala. 2024 -Dabur India Limited has informed the Exchange about Acquisition of Sesa Care Private Limited thorugh merger along with its foreign wholly owned subsidiary.

Read More

Parent Organisation

Dabur India Ltd.

Founded

16/09/1975

Managing Director

Mr.Mohit Burman

NSE Symbol

DABUREQ

FAQ

The current price of Dabur India Ltd is ₹ 487.75.

The 52-week high for Dabur India Ltd is ₹ 490.45 and the 52-week low is ₹ 482.35.

The market capitalization of Dabur India Ltd is currently ₹ 86444.82. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dabur India Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dabur India Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dabur India Ltd shares.

The CEO of Dabur India Ltd is Mr.Mohit Burman, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT